SCHEMBL25643976

SCHEMBL25643976

N#CN=C(NCCCCCCC1CCN(C(=O)c2cccs2)C1)Nc1cc(F)nc(F)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PABPC1 P11940 2/20 0.38
▸ EIF4H Q15056 2/20 0.38
▸ ALDH1A1 P00352 6/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ RIN1 Q13671 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ NAMPT P43490 2/20 0.35
▸ APOBEC3A P31941 1/20 0.35
▸ APOBEC3G Q9HC16 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25642316 1.00 PABPC1 (0.38) PABPC1EIF4HALDH1A1ABL1RIN1
SCHEMBL25643965 0.92 KDM4E (0.38) PABPC1EIF4HALDH1A1ABL1RIN1
SCHEMBL25642301 0.92 KDM4E (0.38) PABPC1EIF4HALDH1A1ABL1RIN1
SCHEMBL25643870 0.92 KDM4E (0.38) PABPC1EIF4HALDH1A1ABL1RIN1
SCHEMBL25642246 0.92 KDM4E (0.38) PABPC1EIF4HALDH1A1ABL1RIN1
SCHEMBL25642321 0.92 PABPC1 (0.39) PABPC1EIF4HALDH1A1ABL1RIN1
SCHEMBL25643990 0.92 PABPC1 (0.39) PABPC1EIF4HALDH1A1ABL1RIN1
SCHEMBL25276731 0.89 PABPC1 (0.42) PABPC1EIF4HALDH1A1ABL1RIN1
SCHEMBL25222442 0.89 PABPC1 (0.42) PABPC1EIF4HALDH1A1ABL1RIN1
SCHEMBL25642165 0.89 PABPC1 (0.42) PABPC1EIF4HALDH1A1ABL1RIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067607-A1 Pyridinylcyanoguanidine Derivative and Use Thereof WANG, ZHEMING (CN) 2024-02-29 — — US disclosed
US-11873284-B2 Pyridinylcyanoguanidine derivative and use thereof WANG, Zheming (CN) 2024-01-16 — — US disclosed
US-20230192615-A1 Pyridinylcyanoguanidine Derivative and Use Thereof Rushi Biotech (Hangzhou) Co., Ltd (CN) 2023-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067607-A1 Pyridinylcyanoguanidine Derivative and Use Thereof NAMPT, NAPRT, NNMT PABPC1 2203/4885EIF4H 4536/4885ALDH1A1 1993/4885
US-11873284-B2 Pyridinylcyanoguanidine derivative and use thereof NAMPT, NAPRT, NNT PABPC1 2223/4885EIF4H 4585/4885ALDH1A1 1855/4885
US-20230192615-A1 Pyridinylcyanoguanidine Derivative and Use Thereof NAMPT, NAPRT, NNT PABPC1 2223/4885EIF4H 4585/4885ALDH1A1 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback